Boston Scientific Non-GAAP EPS of $0.75 beats by $0.04, revenue of $5.07B beats by $100M

* Boston Scientific press release [https://seekingalpha.com/pr/20274850-boston-scientific-announces-results-for-third-quarter-2025] (NYSE:BSX [https://seekingalpha.com/symbol/BSX]): Q3 Non-GAAP EPS of $0.75 beats by $0.04.
* Revenue of $5.07B (+20.4% Y/Y) beats by $100M.
* Reported net sales of $5.065 billion, representing an increase of 20.3 percent on a reported basis, compared to the company's guidance range of 17 to 19 percent; 19.4 percent on an operational basis; and 15.3 percent on an organic basis, compared to the company's guidance range of 12 to 14 percent, all compared to the prior year period.
* MedSurg: 16.4 percent reported, 15.6 percent operational and 7.6 percent organic
* Cardiovascular: 22.4 percent reported, 21.5 percent operational and 19.4 percent organic
* Guidance for Full Year and Fourth Quarter 2025The company estimates net sales growth for the full year 2025, versus the prior year period, to be approximately 20 percent on a reported basis and approximately 15.5 percent on an organic basis.
* The company estimates EPS on a GAAP basis in a range of $1.97 to $2.01 and estimates adjusted EPS, excluding certain charges (credits), of $3.02 to $3.04 vs. $2.98 consensus.
* The company estimates net sales growth for the fourth quarter of 2025, versus the prior year period, to be in a range of approximately 14.5 to 16.5 percent on a reported basis, and 11 to 13 percent on an organic basis.
* The company estimates EPS on a GAAP basis in a range of $0.48 to $0.52 and estimates adjusted EPS, excluding certain charges (credits), of $0.77 to $0.79 vs. $0.76 consensus.
* Shares +2.6% PM.

MORE ON BOSTON SCIENTIFIC

* Boston Scientific: Not In The Most Resolute State As It Approaches Q3 Earnings [https://seekingalpha.com/article/4828727-boston-scientific-not-in-the-most-resolute-state-as-it-approaches-q3-earnings]
* 2025 Investor Day Call [https://seekingalpha.com/article/4827071-2025-investor-day-call]
* Boston Scientific Corporation (BSX) 2025 Investor Day Call (Transcript) [https://seekingalpha.com/article/4827064-boston-scientific-corporation-bsx-2025-investor-day-call-transcript]
* Boston Scientific Q3 2025 Earnings Preview [https://seekingalpha.com/news/4506101-boston-scientific-q3-2025-earnings-preview]
* Earnings week ahead: TSLA, KO, T, INTC, NFLX, F, GM, AAL, LUV, PG, GE, MMM, CLF, AGNC, and more [https://seekingalpha.com/news/4505221-earnings-week-ahead-tsla-ko-t-intc-nflx-vz-f-gm-aal-luv-pg-ge-mmm-clf-agnc-and-more]